PLEASANTON, Calif., Jan. 2, 2025
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in
single cell and spatial biology, announced today that members of
its management team will present at the 43rd Annual J.P.
Morgan Healthcare Conference on Monday,
January 13, at 7:30 a.m. Pacific Time.
Interested parties may access a live webcast of the fireside
chat on the "Investors" section of the company's website at:
https://investors.10xgenomics.com/. The webcast will be archived
and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building
products to accelerate the mastery of biology and advance human
health. Our integrated solutions include instruments, consumables,
and software for single cell and spatial biology, which help
academic and translational researchers and biopharmaceutical
companies understand biological systems at a resolution and scale
that matches the complexity of biology. Our products are behind
breakthroughs in oncology, immunology, neuroscience, and more,
fueling powerful discoveries that are transforming the world's
understanding of health and disease. To learn more,
visit 10xgenomics.com or connect with us
on LinkedIn or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, our website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and our social media
accounts as means of disclosing material non-public information and
for complying with our disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302340408.html
SOURCE 10x Genomics, Inc.
